PAMS
IMCR icon

Pictet Asset Management (Switzerland)’s Immunocore IMCR Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$56.5M Buy
941,773
+52,822
+6% +$3.01M 0.07% 272
2023
Q1 		$43.9M Buy
888,951
+270,636
+44% +$15.2M 0.05% 306
2022
Q4 		$35.3M Buy
+618,315
New +$34.8M 0.05% 329

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s IMCR Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Immunocore (IMCR) stake by 5.9% in Q2 2023, buying an estimated $3.01M and bringing the position to 941,773 shares worth $56.5M. The position accounts for 0.07% of the portfolio, ranked #272.

Pictet Asset Management (Switzerland) first reported a position in IMCR in Q4 2022 and has held it in 3 quarters since. 120 funds tracked by Wall St. Rank hold IMCR as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 941,773 shares of Immunocore worth $56.5M as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 52,822 Immunocore shares in Q2 2023, an estimated $3.01M.
  • Immunocore made up 0.07% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #272 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Immunocore in Q4 2022 and has held it in 3 quarters since.
  • 120 funds tracked by Wall St. Rank held Immunocore as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.